Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Kairos Pharma (KAPA) Amortization - Intangibles (2024)

Kairos Pharma (KAPA) has disclosed Amortization - Intangibles for 1 consecutive years, with $115000.0 as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Amortization - Intangibles changed N/A year-over-year to $115000.0, compared with a TTM value of $154000.0 through Dec 2024, changed N/A, and an annual FY2024 reading of $154000.0, up 175.0% over the prior year.
  • Amortization - Intangibles was $115000.0 for Q3 2024 at Kairos Pharma, up from $19000.0 in the prior quarter.
  • Across five years, Amortization - Intangibles topped out at $115000.0 in Q3 2024 and bottomed at $19000.0 in Q2 2024.